Please assess the completion status of the following clinical trial:

Trial Title: A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 45 years, inclusive~* In good health with no history of major medical conditions~* A total body weight ≥ 50 kg and a body mass index (BMI) of \>/=18kg/m2 and \</=30kg/m2~Exclusion Criteria:~* Evidence of any clinically significant or currently active major medical condition~* Positive for Human Immunodeficiency Virus, active Hepatitis A, B or C test~* Significant nose or nasopharynx abnormalities~* Abnormal lung function~* History or currently active symptoms suggestive of upper or lower respiratory tract infection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- RV521 (Type: EXPERIMENTAL): RV521 drug substance in capsule for oral administration
- Placebo (Type: PLACEBO_COMPARATOR): Micro-crystalline cellulose in capsule for oral administration

Based on this trial design, predict the completion outcome and termination type (if applicable).